Frailty characterization and patient-reported outcomes in patients with ICI-related inflammatory arthritis and polymyalgia rheumatica

Clicks: 26
ID: 331773
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #28 of 77 articles by views in Rheumatology Advances in Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Objectives Immune checkpoint inhibitors (ICIs) have been associated with immune related adverse events (irAEs), including inflammatory arthritis (IA) and polymyalgia rheumatica (PMR). We aimed to (1) characterize frailty status in patients who develop ICI-IA and ICI-PMR and (2) describe patient-reported outcomes (PROs) across key domains of the disease experience, stratified by frailty status. Methods Consecutive new referrals to our Rheumatology-irAE clinic between April 2024 and April 2025 for evaluation of ICI-IA or ICI-PMR were recruited to this cross-sectional study. Frailty and PROs were measured using validated surveys. PROMIS-29 domain scores were summarized descriptively for patients classified as robust/pre-frail versus frail. Given the small sample size, no inferential statistical testing was performed and no p-values are reported. Results A total of 14 patients (eight males and six females) were included, of whom 10 were characterized as robust or pre-frail and four as frail. The mean ages were similar between those robust/prefrail and frail patients. 2 patients in each group had ICI-PMR. 2 patients in the frail group were diagnosed with ICI-IA, compared to 8 patients in the pre-frail group. Frail patients reported higher median scores in the fatigue and pain interference domains (median T-score fatigue 67.9 [IQR 65.5 to 70.6] versus 53.0 [IQR 48.6 to 57.1]; median T-score pain interference 66.7 [IQR 66.4 to 68.9] versus 58.2 [IQR 57.5 to 62.3]). Median social roles and activities and physical function scores were also lower in the frail group. Conclusion In this small cross-sectional cohort, (1) frailty was present in approximately one-third of patients with ICI-related rheumatic irAEs, and (2) patients classified as frail reported higher fatigue and pain interference scores on PROMIS-29. These observations are descriptive and hypothesis-generating, and are intended to inform the design of larger prospective studies of frailty assessment and geriatric-informed care in this population.
Reference Key
openalex_W7220980511 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Rheumatology Advances in Practice
Year 2026
DOI
10.1093/rap/rkag122
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.